hotspot -WSS

hotspot

author：knowledge 2025-09-06 06:00:08 - browse：5

Have you ever seen a mouse with a set of muscles more appropriate for a bodybuilder or comic book superhero?

Well, 25 years ago, researchers at Johns Hopkins University made it happen. By silencing a gene responsible for producing a protein called myostatin, they directed tiny mouse bodies to grow double the amount of lean muscle they would normally, leading to mice with bulky arms, defined pectorals, and an overall more substantial body mass. They were dubbed “mighty mice.”

Now, biotech startups are hoping to use those findings to create what they believe will be better weight loss medications. In the last several months, multiple companies have disclosed they are testing drugs that preserve or grow muscle while reducing fat, as shown in the updated STAT Obesity Drug Tracker. They hope that their drugs, possibly when used in conjunction with existing obesity treatments, will result in healthier weight loss.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： How a small hospital in rural Puerto Rico survived Hurricane Maria

WSS

Is it ever OK for doctors to lie to their patients?

Wayne Brady comes out as pansexual: 'Free to love whomever I want'

Chemotherapy before breast cancer surgery might fuel metastasis

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

Why failed clinical trials don’t always spell doom for a new drug

South Korea throws huge K

entertainment

hotspot

Wikipedia

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Why failed clinical trials don’t always spell doom for a new drug

Jerome Adams on the need for new antivirals for Covid

Welsh Carson private equity firm escapes from FTC antitrust case

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Friends ask where James Watson's attitudes about race came from

New air purifier tech could be key to improving indoor air quality

Lawmakers grill UnitedHealth CEO on Change cyberattack

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Brain MRIs reveal impact of 'toxic stress' on Black children

focus

Lawmakers grill UnitedHealth CEO on Change cyberattack

Why failed clinical trials don’t always spell doom for a new drug

NIH trials fail to test meaningful long Covid therapies, experts say

For Cytokinetics, FDA rejection of heart drug would help, not hinder

PBM executives asked to testify by House panel

Lawmakers grill UnitedHealth CEO on Change cyberattack

explore

hotspot

hotspot

focus